Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists.
D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D000818:Animals; D001067:Appetite Depressants / Q000494:pharmacology; D001552:Benzazepines / Q000494:pharmacology; D002375:Catalepsy / Q000139:chemically induced; D004192:Discrimination, Psychological / Q000187:drug effects; D004298:Dopamine / Q000494:pharmacology; D006120:Grooming / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D017447:Receptors, Dopamine D1; D013239:Stereotyped Behavior / Q000187:drug effects; D013876:Thiophenes / Q000494:pharmacology
D001067:Appetite Depressants; D001552:Benzazepines; D011954:Receptors, Dopamine; D017447:Receptors, Dopamine D1; C053427:SK&F 89615; D013876:Thiophenes; C052506:SK&F 75670; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D004298:Dopamine